BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| xylooligosaccharide - Bifidobacterium biavatii |
👶
Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients With Ulcerative Colitis in Clinical Remission. Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 778542 Pub: 2021 Epub: 2021 Dec 28 Authors Li Z , Li Z , Zhu L , Dai N , Sun G , Peng L , Wang X , Yang Y , Html Article Publication |
| xylooligosaccharide - Bifidobacterium biavatii |
👶
Dose-Dependent Effects of Dietary Xylooligosaccharides Supplementation on Microbiota, Fermentation and Metabolism in Healthy Adult Cats. Molecules (Basel, Switzerland) (Molecules ) Vol: 25 Issue 21 Pages: Pub: 2020 Oct 29 Epub: 2020 Oct 29 Authors Lyu Y , Debevere S , Bourgeois H , Ran M , Broeckx BJG , Vanhaecke L , Wiele TV , Hesta M , Html Article Publication |
| xylooligosaccharide - Bifidobacterium biavatii |
👶
Chronic oral exposure to glycated whey proteins increases survival of aged male NOD mice with autoimmune prostatitis by regulating the gut microbiome and anti-inflammatory responses. Food & function (Food Funct ) Vol: 11 Issue 1 Pages: 153-162 Pub: 2020 Jan 29 Epub: Authors Chen Y , Guo KM , Nagy T , Guo TL , Html Article Publication |
| xylooligosaccharide - Bifidobacterium biavatii |
👶
Dietary xylo-oligosaccharide stimulates intestinal bifidobacteria and lactobacilli but has limited effect on intestinal integrity in rats. BMC research notes (BMC Res Notes ) Vol: 7 Issue Pages: 660 Pub: 2014 Sep 19 Epub: 2014 Sep 19 Authors Christensen EG , Licht TR , Leser TD , Bahl MI , Html Article Publication |
| xylooligosaccharide - Bifidobacterium biavatii |
👶
Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium. Food science & nutrition (Food Sci Nutr ) Vol: 12 Issue 2 Pages: 1119-1132 Pub: 2024 Feb Epub: 2023 Nov 27 Authors Yi W , Wang Q , Xue Y , Cao H , Zhuang R , Li D , Yan J , Yang J , Xia Y , Zhang F , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
